H. R. HYGIENE PRODUCTS LIMITED
	CORPORATE IDENTITY NUMBER: U74999GJ2016PLC093028

1. Top 5 Risks:

i. There is change in statutory auditor from the filing of DRHP. The Company has appointed new statutory auditor. The cessation was not on account of any disagreement with the Company relating to the financial statements, accounting policies, auditing procedures, internal financial controls, management representations or any reportable event under the applicable provisions of the Companies Act, 2013.

ii. There are certain outstanding legal proceeding involving our Company, Group Company, Promoters, Directors and KMP and SMP which may adversely affect our business, financial condition and results of operations.

iii. Our revenue from operations is highly concentrated in one product category and any adverse development affecting such category could materially and adversely affect our business.

iv. Our inability to timely adapt to changing consumer preferences, spending patterns, or hygiene and personal care trends may reduce demand for our products, adversely affecting our business, results of operations, financial condition, and cash flows.

v. Our brands and reputation constitute critical assets of our Company and any deterioration in them could materially and adversely affect our business, financial condition, cash flows and results of operations.

For details refer to Chapter titled 'Risk Factors' beginning on page 21 of the Prospectus.

2. The average cost of acquisition of Equity Shares held by our Promoters and Promoter Selling Shareholders is as follows:

* As certified by Savjani & Associates, statutory auditors, vide their certificate dated July 31,2026

3. Weighted Average Cost of Acquisition

^ There were no primary / new issue of shares (equity/convertible securities).

^^ There were no secondary sales / acquisition of shares (equity/ convertible securities) transactions in last 18 months from the date of the Prospectus.

As certified by Savjani & Associates, statutory auditors, vide their certificate dated July 31,2026 4. The Merchant Banker associated with the Issue has handled following public issues in the past three financial years which were closed below the issue price on the listing date.

This Issue is being made in terms of Rule 19(2)(b) of the SCRR, through the Book Building Process in accordance with Regulation 253 of the SEBI ICDR Regulations wherein not more than 50.00% of the Offer shall be allocated on a proportionate basis to QIBs, allocate up to 60% of the QIB Portion to Anchor Investors and forty per cent of the anchor investor portion, shall be reserved as under - (i) 33.33 per cent for domestic mutual funds; and (ii) 6.67 per cent for life insurance companies and pension funds: Any under-subscription in the reserved category specified in clause (ii) above may be allocated to domestic mutual funds., subject to valid Bid received from Mutual Funds at or above the Anchor Investor Allocation Price on a discretionary basis in accordance with the SEBI ICDR Regulations. Further, 5.00% of the QIB Portion shall be available for allocation on a proportionate basis only to Mutual Funds, and spill-over from the remainder of the QIB Portion shall be available for allocation on a proportionate basis to all QIBs, including Mutual Funds, subject to valid Bids being received at or above the Offer Price. Further, not less than 15.00% of the Issue shall be available for allocation on a proportionate basis to Non-Institutional Bidders and not less than 35.00% of the Issue shall be available for allocation to Individual Bidders in accordance with the SEBI ICDR Regulations, subject to valid Bids being received at or above the Offer Price. Under-subscription, if any, in any category, except in the QIB Portion, would be allowed to be met with spill over from any other category or combination of categories of Bidders at the discretion of our Company, in consultation with the BRLM and the Designated Stock Exchange subject to receipt of valid Bids received at or above the Offer Price. Under- subscription, if any, in the QIB Portion, would not be allowed to be met with spill-over from any other category or a combination of categories. For details, see "Offer Procedure" beginning on page 292 of the Prospectus. The investors are advised to refer to the prospectus for the full text of the Disclaimer clause pertaining to BSE. For the purpose of this Issue, the Designated Stock Exchange will be BSE Limited ("BSE"). The trading is proposed to commence on Wednesday, August 05, 2026*.

*Subject to the listing and trading approval from the SME Platform of BSE Limited.

The Net offer has received 5,554 valid applications for 2,79,63,200 Equity Shares resulting in 6.29 times subscription. The details of the applications received in the Net Issue (After removing multiple and duplicate bids, bids (UPI Mandates) not accepted by investors/ blocked, bids rejected under application banked but bid not registered and valid rejections cases from the 'Bid Book') are as follows:

The Basis of allotment was finalized in consultation with the Designated Stock Exchange, being BSE Limited (SME Platform of BSE Limited) on Monday, August 03, 2026 and in view of the explanation provided under regulations 253 (2) of the SEBI (ICDR) Regulation, 2018,

1. Allocation to Individual Investors (After Rejections): The Basis of Allotment to the Individual Investors, who have bid at or above the Offer Price of Rs. 88.00/- per equity shares, was finalized in consultation with BSE. The category was subscribed by 6.80 times i.e. for 1,38,62,400 Equity Shares. Total number of shares allotted in this category is 20,38,400 Equity Shares to 637 successful applicants. The category wise details of the Basis of Allotment as under:

2. Allocation to Non-Institutional Investors 1 (After Rejections): The Basis of Allotment to Non-Institutional Investors 1, who have bid at Offer Price of Rs. 88.00/- per equity shares or above, was finalized in consultation with BSE. The category was subscribed by 10.81 times i.e.; for 31,47,200 Equity Shares. The total number of shares allotted in this category is 2,91,200 Equity Shares to 60 successful applicants. The category wise details of the Basis of Allotment are as under:

3. Allocation to Non-Institutional Investors 2 (After Rejections): The Basis of Allotment to Non-Institutional Investors 2, who have bid at Offer Price of Rs. 88.00/- per equity shares or above, was finalized in consultation with BSE. The category was subscribed by 12.39 times i.e.; for 72,17,600 Equity Shares. The total number of shares allotted in this category is 5,82,400 Equity Shares to 121 successful applicants. The category wise details of the Basis of Allotment are as under:

4. Allocation to QIBs excluding Anchor Investors (After Rejections): The Basis of Allotment to QIBs, who have bid at Offer Price of Rs. 88.00/- per Equity Shares or above, was finalized in consultation with BSE. The category was subscribed by 2.80 times i.e. for 34,25,600 Equity shares. The total number of shares allotted in this category is 12,22,400 Equity Shares to 9 successful applicants. The category wise details of the Basis of Allotment are as under:

5. Allocation to Anchor Investors (After Rejections): The Company in consultation with the BRLM has allotted 16,86,400 Equity Shares to 7 Anchor Investors at Anchor Investor Offer Price of Rs. 88.00/- per Equity Shares in accordance with the SEBI ICDR Regulations. The category wise details of the Basis of Allotment are as under:

6. Allocation to Market Maker (After Rejections): The Basis of Allotment to Market Maker who have bid at Offer Price of Rs. 88.00/- per Equity Shares or above, was finalized in consultation with BSE. The category was subscribed by 1.00 time i.e.; for 3,10,400 Equity shares. The total number of shares allotted in this category is 3,10,400 Equity Shares. The category wise details of the Basis of Allotment are as under:

The Board of Directors of our Company at its meeting held on Monday, August 03, 2026 has taken on record the basis of allotment of Equity Shares approved by the designated Stock Exchange, being BSE and has allotted the Equity Shares to various successful applicants. The Allotment Advice Cum Refund Intimation will be dispatched to the address of the investors as registered with the depositories. Further, instructions to the SCSBs have been dispatched / mailed for unblocking of funds and transfer to the Public Issue Account on or before Tuesday, August 04, 2026. In case the same is not received within four working days, Investors may contact the Registrar to the Issue at the address given below. The Equity Shares allotted to the successful allottees shall be uploaded on Tuesday, August 04, 2026 for credit into the respective beneficiary accounts subject to validation of the account details with the depositories concerned. The Company is in the process of obtaining the listing and trading approval from BSE and the trading of the Equity Shares is expected to commence trading on Wednesday, August 05, 2026.

Note: All Capitalized terms used and not defined herein shall have respective meanings assigned to them in the prospectus dated July 31, 2026 filed with Registrar of Company (RoC), Ahmedabad at Gujarat.

Allotment details are available on the website of the Registrar to the Issue, Purva Sharegistry (India) Private Limited, at www.purvashare.com. For future correspondence, please quote your full name, ASBA form serial number, number of shares bid, DP ID, Client ID, PAN, submission date, address, designated intermediary details, acknowledgment slip, and payment details to the address below:

THE LEVEL OF SUBSCRIPTION SHOULD NOT BE TAKEN TO BE INDICATIVE OF EITHER THE MARKET PRICE OF THE EQUITY SHARES ON LISTING OR THE BUSINESS PROSPECTS OF H.R. HYGIEN PRODUCTS LIMITED.

Disclaimer: H.R. Hygiene Products Limited is proposing, subject to market conditions, public issue of its equity shares and had filed the Prospectus with the Registrar of Companies, Ahmedabad at Gujarat. The Prospectus is available on the website of SEBI at www.sebi.gov.in, the website of the Book Running Lead Manager at www.ib.marwadichandaranagroup.com, website of the BSE at www.bseindia.com and website of Issuer Company at www.hrhygiene.com Investors should note that investment in Equity Shares involves a high degree of risk. For details, investors shall refer to and rely on the Prospectus including the section titled "Risk Factors" beginning on page 21 of the Prospectus, which has been filed with ROC. The Equity Shares have not and will not be registered under the US Securities Act (the "Securities Act") or any state securities law in United States and may not be Issued or sold within the United States or to, or for the account or benefit of, "U.S. persons" (as defined in the Securities Act), except pursuant to an exemption from, or in a transaction not subject to the registration requirements of the Securities Act of 1933.